Cargando…
IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis
BACKGROUND: Methotrexate (MTX) is the standard first-line therapy in rheumatoid arthritis (RA) with variable clinical efficacy that is difficult to predict. The glycosylation status of immunoglobulin G (IgG) is altered in RA and influenced by MTX treatment. We aimed to further investigate if IgG gly...
Autores principales: | Lundström, Susanna L., Hensvold, Aase H., Rutishauser, Dorothea, Klareskog, Lars, Ytterberg, A. Jimmy, Zubarev, Roman A., Catrina, Anca I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549282/ https://www.ncbi.nlm.nih.gov/pubmed/28793911 http://dx.doi.org/10.1186/s13075-017-1389-7 |
Ejemplares similares
-
IgG Antibodies to Cyclic Citrullinated Peptides Exhibit Profiles Specific in Terms of IgG Subclasses, Fc-Glycans and a Fab-Peptide Sequence
por: Lundström, Susanna L., et al.
Publicado: (2014) -
Altered Fc galactosylation in IgG(4) is a potential serum marker for chronic lung disease
por: Heyder, Tina, et al.
Publicado: (2018) -
IgG1 Fc N-glycan galactosylation as a biomarker for immune activation
por: de Jong, Sanne E., et al.
Publicado: (2016) -
Molecular signature of methotrexate response among rheumatoid arthritis patients
por: Brynedal, Boel, et al.
Publicado: (2023) -
Is IgG galactosylation the relevant factor for pregnancy-induced remission of rheumatoid arthritis?
por: Förger, Frauke, et al.
Publicado: (2010)